packard model 307 oxidizer (Revvity)
Revvity is a verified supplier 
Revvity manufactures this product 
94
Structured Review
Revvity
packard model 307 oxidizer
Packard Model 307 Oxidizer, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 290 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/packard+model+307+oxidizer/Model+A307+Sample+Oxidizer/pm41043266-76-12-19
Average 94 stars, based on 290 article reviews
Packard Model 307 Oxidizer, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 290 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/packard+model+307+oxidizer/Model+A307+Sample+Oxidizer/pm41043266-76-12-19
Average 94 stars, based on 290 article reviews
packard model 307 oxidizer - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: Pharmacokinetics and metabolism in rats, dogs, and monkeys of the cathepsin k inhibitor odanacatib: demethylation of a methylsulfonyl moiety as a major metabolic pathway. Article Snippet: Odanacatib is a potent cathespin K inhibitor that is being developed as a novel therapy for osteoporosis.. The disposition and metabolism of odanacatib were evaluated in rats, dogs, and rhesus monkeys after intravenous and oral administration of [C]odanacatib.. Odanacatib was characterized by low systemic clearance in all species and by a long plasma half-life in monkeys (18 h) and dogs (64 h). Article Title: Absorption, distribution, and elimination of [ 14 C] polyethylene terephthalate nanoplastics in lactating sheep upon oral administration. Article Snippet: • The majority of orally dosed [14C] PET NP was eliminated in sheep feces.. • [14C] PET NP had a long elimination half-life in plasma.. • Trace amounts of administered [14C] PET NP were present in milk. Article Title: Disposition and pharmacokinetics of L-N6-(1-iminoethyl)lysine-5-tetrazole-amide, a selective iNOS inhibitor, in rats. Article Snippet: The metabolism, pharmacokinetics, tissue distribution, and excretion of L-N6-(1-iminoethyl)lysine-5-tetrazole-amide (L-NIL-TA), a selective inducible NO synthase (iNOS) inhibitor, were investigated in rats.. [C]L-NIL-TA is extensively metabolized after either oral or IV administration with a minor amount (<1%) excreted as the prodrug.. L-NIL-TA is metabolized via a single hydrolysis pathway to form the active drug, L-N6-(1-iminoethyl)lysine (L-NIL). Homogenization:Article Title: Species-dependent metabolism of a novel selective α7 neuronal acetylcholine receptor agonist ABT-107. Article Snippet: Metabolism of ABT-107 was investigated in in vitro hepatic systems, in rat and monkey receiving [C]ABT-107, and in vivo plasma in rat, dog, monkey and human.. In in vitro hepatic systems, ABT-107 was primarily cleared via oxidative metabolism, and proceeded via two parallel pathways.. Pathway 1, ABT-107 was oxidized at the nitrogen of quinuclidine moiety to form M1. Article Title: Metabolism and disposition of ABT-894, a novel α4β2 neuronal acetylcholine receptor agonist, in mice and monkeys. Article Snippet: Metabolism and disposition of ABT-894 was investigated in hepatocytes, in mice and monkeys receiving [C]ABT-894.. In hepatocytes, turnover rate of ABT-894 was slow in all species with more than 90% of parent remaining.. M3 (carbamoyl glucuronide) and M6 (mono-oxidation) were detected across species. |